Last €11.10 EUR
Change Today +0.01 / 0.09%
Volume 185.7K
GLB On Other Exchanges
Symbol
Exchange
OTC US
Dublin
London
OTC US
As of 12:10 PM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).

glanbia plc (GLB) Snapshot

Open
€11.26
Previous Close
€11.09
Day High
€11.26
Day Low
€11.01
52 Week High
05/20/13 - €11.26
52 Week Low
06/15/12 - €5.08
Market Cap
3.3B
Average Volume 10 Days
427.6K
EPS TTM
€0.42
Shares Outstanding
295.5M
EX-Date
04/17/13
P/E TM
26.1x
Dividend
€0.09
Dividend Yield
0.82%
Current Stock Chart for GLANBIA PLC (GLB)

Related News

No related news articles were found.

glanbia plc (GLB) Related Businessweek News

View More BusinessWeek News

glanbia plc (GLB) Details

Glanbia plc operates as a nutritional solutions and cheese company. The company manufactures and sells cheese, whey protein, dairy consumer products, and other nutritional products; and animal feed products and other farm inputs. It also offers various vitamins, minerals, and other nutrients; and protein based fitness and healthy living products, as well as pre-workout energy, post-workout recovery, and diet and muscle building products. In addition, the company sells a range of farm related inputs, including feed, fertilizer, hardware, and veterinary supplies; manufactures soups; manufactures and co-packs nutritional beverages, such as premium super-fruit drinks, vitamin shots, and protein shakes; and engages in property and land dealing, nutrient delivery systems, and fertilizers businesses. It sells it products worldwide. The company was founded in 1964 and is based in Kilkenny, Ireland.

3,823 Employees
Last Reported Date: 04/20/13
Founded in 1964

glanbia plc (GLB) Top Compensated Officers

Group Managing Director, Executive Director a...
Total Annual Compensation: €1.5M
Group Finance Director and Director
Total Annual Compensation: €930.0K
Compensation as of Fiscal Year 2012.

glanbia plc (GLB) Key Developments

Glanbia plc Announces Interim Management Statement for the Four Month Period to April 27, 2013

Glanbia plc announced Interim Management Statement for the four month period to 27 April 2013. For the period the company reported total group revenue grew almost 9% in the four months to the end of April compared to the same period in 2012. This comprised approximately 5% volume and 4% price growth. Glanbia's net debt as at 27 April 2013 was €459 million. Net debt to 12 month rolling adjusted EBITDA at the same date was 2.1 times which was an improvement on the same period in 2012 of 2.4 times. Committed debt facilities amounted to €758 million with €39 million maturing in July 2014, €469 million maturing in January 2018 and $325 million (€250 million) maturing in June 2021. For 2013 the company have a significant capital expenditure programmed in the region of €130 million and financing strategy supports debt capacity to fund up to €200 million acquisition expenditure.

Glanbia To Acquire WFC Branch

Glanbia plc is seeking to acquire Bunclody branch of Wexford Farmers Co-Operative Society Ltd (WFC). A spokesperson for Glanbia said that a deal regarding the WFC branch had not been finalized but she admitted that Glanbia were in discussions regarding the business.

Glanbia plc Announces Audited Group Earnings Results for the Year Ended December 29, 2012; Recommends Final Dividend Payable on May 31, 2013; Provides Financial Guidance for 2013

Glanbia plc announced audited group earnings results for the year ended December 29, 2012. For the period, the company reported revenue of €2,211,757,000 compared to €1,932,849,000 a year ago period. EBITA was €177,452,000 against €132,603,000 a year ago period. Operating profit was €157,588,000 against €114,656,000 a year ago period. Profit before taxation was €149,307,000 against €105,576,000 a year ago period. Profit for the year from continuing operations was €125,247,000 or 42.07 cents per diluted share against €84,005,000 or 28.17 cents per diluted share a year ago period. Profit attributable to equity holders of the parent was €143,790,000 or 48.47 cents per diluted share against €112,178,000 or 37.90 cents per diluted share a year ago period. Net cash inflow from operating activities was €73,046,000 against €106,053,000 a year ago period. Purchase of property, plant and equipment was €65,893,000 against €38,310,000 a year ago period. Purchase of intangible assets was €4,119,000 against €1,646,000 a year ago period. Net debt at the end of the year was €376,560,000 against €480,331,000 a year ago period. Adjusted net income from continuing operations was €150,007,000 or 50.56 cents per diluted share against €118,417,000 or 40.01 cents per diluted share a year ago period. On a reported currency basis, proforma total group revenue was €3,038.1 million and EBITA was €213.6 million compared with total group revenue of €32,752.4 million and EBITA of €181.8 million a year ago period. This growth in revenue was driven primarily by positive pricing and volume growth in the Global Nutritionals businesses, which drove a 20% increase in revenue across the three nutritional business units. The company yielded about a 14% return on capital. The Board is recommending a final dividend of 5.43 cents per share compared to a final dividend of 4.94 cents per share paid in 2011. This represents an increase of 10% in the year and brings the total dividend for the year to 9.09 cents per share compared to 8.27 cents per share paid in 2011. Subject to shareholders approval, this dividend will be paid on 31 May 2013 to shareholders on the register of members at 19 April 2013, the record date. The company provided financial guidance for 2013. The company is guiding 8% to 10% year-on-year growth in adjusted earnings per share, on a constant currency basis, from 51.02 cents, which takes into account the dilutive effect of the GIIL transaction. There are some headwinds with an uncertain global economic environment and challenging Irish retail environment, but the Group is well positioned to maintain its growth momentum.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLB:ID €11.10 EUR +0.01

GLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dairy Crest Group PLC 472.00 GBp +1.00
Greencore Group PLC 118.00 GBp -0.50
Herbalife Ltd $49.21 USD +4.77
Premier Foods PLC 73.75 GBp +0.25
Tate & Lyle PLC 855.00 GBp +5.00
View Industry Companies
 

Industry Analysis

GLB

Industry Average

Valuation GLB Industry Range
Price/Earnings 25.6x
Price/Sales -- Not Meaningful
Price/Book 5.9x
Price/Cash Flow 16.9x
TEV/Sales 1.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLANBIA PLC, please visit www.glanbia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.